Rein Therapeutics(DE:015A)
€3.140.00 (0.00%)
DE:015A
Rein Therapeutics earnings date
€3.14
At close:0.00 (0.00%)
Rein Therapeutics (015A) Q4 2023 Earnings Report
1 Followers
DE:015A Q4 2023 EPS Results
- Actual EPS
- -EUR 0.78
- Consensus EPS
- -EUR 0.13
- Beat/Miss
- Missed by -EUR 0.65
- One Year Ago EPS
- -EUR 0.95
DE:015A Q4 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 04/15/2024
- Time
- After Close
- Conference Call
- Monday, April 15, 2024
DE:015A Upcoming Earnings
Rein Therapeutics's next earnings date is estimated for May 20, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:015A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 20, 2027 | 2027 (Q1) | ―- | -0.17 | ― | ― |
| Nov 06, 2026 | 2026 (Q3) | -0.09- | -0.19 | ― | |
| Aug 14, 2026 | 2026 (Q2) | -0.15-0.09 | -0.25 | 64.29% (+0.16) | |
| May 20, 2026 | 2026 (Q1) | ―- | -0.23 | ― | |
| Apr 06, 2026 | 2025 (Q4) | -0.44-0.17 | -0.23 | 24.00% (+0.05) | |
| Nov 14, 2025 | 2025 (Q3) | -0.22-0.19 | -0.24 | 22.22% (+0.05) | |
| Aug 06, 2025 | 2025 (Q2) | -0.20-0.25 | -0.41 | 37.33% (+0.15) | |
| May 15, 2025 | 2025 (Q1) | ―-0.23 | -0.78 | 70.93% (+0.55) | |
| Apr 07, 2025 | 2024 (Q4) | -0.19-0.23 | -0.78 | 70.93% (+0.55) | |
| Nov 14, 2024 | 2024 (Q3) | -0.22-0.24 | -0.36 | 32.50% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
